Patient Satisfaction With Auditable Pharmaceutical Transactions and Services: A Cross-Sectional Study at Bule Hora University Teaching Hospital, Ethiopia. [PDF]
Gerina A, Wariyo Guyo A, Elema W.
europepmc +1 more source
Improvement in medication adherence is often proposed as a potential advantage of pharmacogenetic‐guided prescribing over a traditional one‐size‐fits‐all approach. This paper provides a review of the published literature and presents the findings of studies that measure adherence to medication as an outcome of pharmacogenetic‐informed care, or that ...
Lucy Galloway +2 more
wiley +1 more source
German Federal Association of Hospital Pharmacists national survey of clinical pharmacy services in Germany, 2024. [PDF]
Hilgarth H +4 more
europepmc +1 more source
Benzodiazepines use in primary care England: Prescribing patterns and adverse consequences
Aims Benzodiazepines (BZDs) are commonly prescribed for anxiety and insomnia but carry risks such as dependence, adverse drug reactions (ADRs) and mortality. Despite deprescribing efforts, the influence of recent prescribing trends, COVID‐19 and adverse outcomes on prescribing patterns in England remains uncertain.
Alvina Chaudhry +3 more
wiley +1 more source
Trends in HPV vaccination among adults aged 27-45 years in the United States. [PDF]
Fisher-Borne M +9 more
europepmc +1 more source
Economic evaluations of antiobesity medications: A systematic literature review
The global prevalence of obesity is rising rapidly. With several antiobesity medications approved and many more in development, understanding their economic value is increasingly important. This study reviews full economic evaluations of approved antiobesity medications to assess cost‐effectiveness and inform reimbursement and access decisions.
Martina Jurković +5 more
wiley +1 more source
<i>"It's Worth Its Weight in Gold"</i>: Patient Reported Experience Measures of a National NHS-Funded Community Pharmacy-Based Common Ailments Service. [PDF]
Mantzourani E +6 more
europepmc +1 more source
Aims This study aimed to analyse clinical investigation‐device initial submissions received by the MHRA between January 2022 and December 2025. Methods Data on submissions were extracted from the clinical investigations unit data bank; software as medical devices were not included. The predefined primary end‐point was submission type.
Andrea Manfrin +7 more
wiley +1 more source
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga +2 more
wiley +1 more source
Substance Use Severity, Autonomy, and Service Utilization Across Psychiatric Care Pathways in Romania: A Cross-Sectional Service Evaluation. [PDF]
Tanase E +8 more
europepmc +1 more source

